5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with lidocaine in 1 studies
| Studies (5-(tetradecyloxy)-2-furancarboxylic acid) | Trials (5-(tetradecyloxy)-2-furancarboxylic acid) | Recent Studies (post-2010) (5-(tetradecyloxy)-2-furancarboxylic acid) | Studies (lidocaine) | Trials (lidocaine) | Recent Studies (post-2010) (lidocaine) |
|---|---|---|---|---|---|
| 51 | 0 | 16 | 26,090 | 5,904 | 5,591 |
| Protein | Taxonomy | 5-(tetradecyloxy)-2-furancarboxylic acid (IC50) | lidocaine (IC50) |
|---|---|---|---|
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elias, PM; Feingold, KR; Gao, WN; Guy, RH; Thornfeldt, CR; Tsai, JC | 1 |
1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and lidocaine
| Article | Year |
|---|---|
Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Topics: Acetone; Administration, Cutaneous; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Cholesterol Esters; Fatty Acids; Fatty Acids, Monounsaturated; Fluvastatin; Furans; Hypolipidemic Agents; Indoles; Lidocaine; Male; Mice; Mice, Hairless; Permeability; Skin; Skin Absorption | 1996 |